Join the Innovation Forum & Shape the Future of Deep-Tech Innovation The Innovation Forum is delighted to announce a partnership with LQD Capital! Through this partnership, the Innovation Forum will support LQD in their search and due-diligence of start-ups in five key areas: Advanced Computing Biotech Applied AI Advanced Engineering TechBio   We are activelyaaa

Tickets for our latest Healthcare 2.0 event, exploring the potential of cell and gene therapies, are available HERE. Over the last thirty years, the field of gene therapy has not only persisted but also achieved significant advancements, providing lasting treatments for an increasingly varied range of diseases. Currently, active clinical trials are addressing a spectrum ofaaa

Tickets for our latest Healthcare 2.0 event, exploring the potential of cell and gene therapies, are available HERE.   The role of cell therapy in heart treatment Cell-based therapy is a cutting-edge approach for treating heart problems, backed by over ten years of careful studies on cells and how they work. After completing initial safetyaaa

Imagine a world where healthcare is streamlined, optimised, and efficient thanks to the power of artificial intelligence. A world where a trip to the doctor’s office is hassle-free and appointments are available at a time that suits you. A world where diagnosis and treatment start as early as possible to give everyone the best possibleaaa

Narges Sheikhansari: Tell us about your team. What are your backgrounds and what is your founding story? Tanay Bhatt: At this stage of pre-expansion, we have a small team consisting of Professor Colin Jamora, Ms. Shreyaa, and myself. I did my PhD under Prof. Colin’s guidance, on the topics of wound-healing, antimicrobial resistance (AMR), and skin associatedaaa

This is an extract of our conversation with Eleanor, Craig and Franck from   VRS Recruitment. If you’re interested in the full interview, you can check it out here. Tatana: What do you think is the unique advantage of VRS? Craig: Recruitment agencies generally have quite a bad reputation. I think what makes us different isaaa

The Innovation Forum is excited to announce a strategic partnership with Discovery Park, a leading UK science park based in Kent, UK. This will help to elevate start-ups in the life sciences industry and open up networks between innovators and the wider science community. Located in the East of England’s life sciences cluster, with closeaaa

One of the major goals of the last decade’s scientific research has been to extend human life. A great deal of resources has been deployed in finding treatments to reduce mortality, both in terms of scientists and research funding.  There is no doubt we have witnessed unforeseen improvements in the human life-span. In 2019, lifeaaa

As technology and medicine become more entwined, it has become clear that at some point — in the near future — digital health will dominate healthcare. What this means specifically will be difficult to define, because digital practices will take innumerable forms. Generally though, it simply means that we will begin to depend more andaaa

Innovator of the Month Interview by Davide Coda and Gian Franco Piredda.   Novigenix is an innovative Swiss molecular diagnostics company specialising in new generation blood tests for early detection of cancer and precision medicine. Founded in 2013, by a group of three scientists from École Polytechnique Fédérale de Lausanne (EPFL), the company is currentlyaaa